Jacqueline Corrigan-Curay, the top FDA drug regulator, acknowledged that much is still in flux at the agency and introduced a new deputy.

Corrigan-Curay has been with the FDA for more than eight years and assumed the acting CDER director role earlier this year after the center's former director, Patrizia Cavazzoni, M.D., stepped ...

WASHINGTON — Jacqueline Corrigan-Curay, the top drug regulator at the Food and Drug Administration, is retiring from the agency in July. Corrigan-Curay, who took over as acting director of the ...

The FDA is giving consumers one month to comment on a proposed method for ranking chemicals in food. The new method would involve a systematic and ...

The Food and Drug Administration has officially launched "Elsa," a generative artificial intelligence platform designed to help staff across the agency work more efficiently. However, internal ...

The FDA first approved mifepristone about a quarter of a century ago, and it's proven to be safe and effective. So why is the FDA reviewing it again?

The Food and Drug Administration is rewriting America’s Covid vaccine playbook, limiting the vaccine based on age and risk factors.

The Food and Drug Administration on Friday approved the first at-home test to screen for cervical cancer, Teal Health, which makes the test kit, said.

The FDA is delaying implementation of a rule that would require food companies to print nutritional information on the front labels of their products.

The new FDA vaccine chief, Dr. Vinay Prasad was an outspoken critic of the agency's response to the pandemic, including the former vaccine chief, Dr. Peter Marks.

The Food and Drug Administration is again trying to rehire some staffers who were recently fired amid mass layoffs at the agency.

The Food and Drug Administration has had to suspect food quality and safety checks following the firing of thousands of employees.